Skip to main content
Erschienen in: Journal of Neuro-Oncology 1/2019

03.01.2019 | Clinical Study

Prognostic factors of patients with spinal malignant melanoma after surgical intervention: a case series of 21 patients and literature review

verfasst von: Zhichao Zhang, Haiyi Gong, Chenglong Zhao, Dongsheng Wang, Ming Qian, Zhipeng Wu, Jianru Xiao

Erschienen in: Journal of Neuro-Oncology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Spinal malignant melanoma (SMM) is a rare type of tumor that can cause nerve roots or spinal cord compression. Patients often suffer from fierce pain and paralyzation. And the estimated survival time were less than 6 months. Surgical interventions to remove the tumor and decompress the nearby nerve roots and spinal cord are effective management. Unfortunately, there lack a thorough and persuasive surgical guideline that specifically aims for this disease. It is necessary to obtain some clinical prognostic factors that predict the recurrence rate and overall survival (OS) of patients with SMM who underwent surgical interventions.

Methods

21 patients with SMM who underwent surgical intervention were retrospectively reviewed. Related patients factors, treatment factors and tumor factors were acquired and subjected into survive analyses using Kaplan–Meier method and the log-rank test. Further Cox proportional hazards model was used to identify independent prognostic factors. Literature regarding surgical interventions on SMM patients were reviewed and summarized as well.

Results

Surgical approach total en-bloc spondylectomy (TES/Piecemeal) (p = 0.015, B 0.029, 95%CI 0.002–0.508), preoperative Frankel grade (A–C/D–E) (p = 0.021, B 15.041, 95%CI 1.492–151.669) and tumor metastases (Yes/No) (p = 0.013, B 16.667, 95%CI 1.805–153.897) are independent prognostic factors for recurrence free survival (RFS). Preoperative Frankel grade (A–C/D–E) (p = 0.031, B 10.676, 95%CI 1.241–91.877) is independent prognostic factors for OS. 12 literatures have been reviewed, including 11 case reports and one retrospective study.

Conclusions

Surgical interventions for patients with SMM are beneficial. Surgical approach (TES/piecemeal), tumor origin (primary/metastasis) and preoperative Frankel grade (A–C/D–E) are independent risk factors in predicting RFS. Preoperative Frankel grade (A–C/D–E) is independent prognostic factor in predicting OS.
Literatur
1.
Zurück zum Zitat Domingues B, Lopes JM, Soares P, Pópulo H (2018) Melanoma treatment in review. Immunotarget Ther 7:35–49CrossRef Domingues B, Lopes JM, Soares P, Pópulo H (2018) Melanoma treatment in review. Immunotarget Ther 7:35–49CrossRef
2.
Zurück zum Zitat Stubblefield J, Kelly B (2014) Melanoma in non-caucasian populations. Surg Clin N Am 94:1115–1126 (ix)CrossRefPubMed Stubblefield J, Kelly B (2014) Melanoma in non-caucasian populations. Surg Clin N Am 94:1115–1126 (ix)CrossRefPubMed
3.
Zurück zum Zitat McLaughlin JP, Fung AT, Shields JA, Shields CL (2013) Iris melanoma in children: current approach to management. Oman J Ophthalmol 6:53–55PubMedPubMedCentral McLaughlin JP, Fung AT, Shields JA, Shields CL (2013) Iris melanoma in children: current approach to management. Oman J Ophthalmol 6:53–55PubMedPubMedCentral
4.
5.
Zurück zum Zitat Zekri J, Marples M, Taylor D, Kandukurti K, McParland L, Brown JE (2017) Complications of bone metastases from malignant melanoma. J Bone Oncol 8:13–17CrossRefPubMedPubMedCentral Zekri J, Marples M, Taylor D, Kandukurti K, McParland L, Brown JE (2017) Complications of bone metastases from malignant melanoma. J Bone Oncol 8:13–17CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Gokaslan ZL, Aladag MA, Ellerhorst JA (2000) Melanoma metastatic to the spine: a review of 133 cases. Melanoma Res 10:78–80CrossRefPubMed Gokaslan ZL, Aladag MA, Ellerhorst JA (2000) Melanoma metastatic to the spine: a review of 133 cases. Melanoma Res 10:78–80CrossRefPubMed
7.
Zurück zum Zitat Moser JC, Grossman KF (2018) Adjuvant therapy for resected high-risk melanoma. Semin Cutan Med Surg 37:109–111CrossRefPubMed Moser JC, Grossman KF (2018) Adjuvant therapy for resected high-risk melanoma. Semin Cutan Med Surg 37:109–111CrossRefPubMed
8.
Zurück zum Zitat Johnson DB, Chon J, Johnson MR, Balko JM (2018) Biomarkers for immune therapy in melanoma. Semin Cutan Med Surg 37:120–126CrossRefPubMed Johnson DB, Chon J, Johnson MR, Balko JM (2018) Biomarkers for immune therapy in melanoma. Semin Cutan Med Surg 37:120–126CrossRefPubMed
9.
Zurück zum Zitat Zhao C, Zhang Z, Zhong N et al (2018) Outcomes and prognostic factors for surgically treated patients with breast cancer spine metastases. J Bone Oncol 12:38–43CrossRefPubMedPubMedCentral Zhao C, Zhang Z, Zhong N et al (2018) Outcomes and prognostic factors for surgically treated patients with breast cancer spine metastases. J Bone Oncol 12:38–43CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Gao X, Zhao C, He S et al (2018) Treatment and outcomes of 28 patients with spinal metastasis from gynecological cancer. J Neurooncol 137:387–394CrossRefPubMed Gao X, Zhao C, He S et al (2018) Treatment and outcomes of 28 patients with spinal metastasis from gynecological cancer. J Neurooncol 137:387–394CrossRefPubMed
11.
Zurück zum Zitat Sellin JN, Gressot LV, Suki D et al (2015) Prognostic factors influencing the outcome of 64 consecutive patients undergoing surgery for metastatic melanoma of the spine. Neurosurgery 77:386–393 (discussion 393)CrossRefPubMed Sellin JN, Gressot LV, Suki D et al (2015) Prognostic factors influencing the outcome of 64 consecutive patients undergoing surgery for metastatic melanoma of the spine. Neurosurgery 77:386–393 (discussion 393)CrossRefPubMed
12.
Zurück zum Zitat Buchanan RCM, Kirksey K (2016) Poster 275 acute encephalopathy in the setting of paraplegia secondary to metastatic melanoma to the lumbar spine: a case report. PM R 8:S249–S249S250CrossRef Buchanan RCM, Kirksey K (2016) Poster 275 acute encephalopathy in the setting of paraplegia secondary to metastatic melanoma to the lumbar spine: a case report. PM R 8:S249–S249S250CrossRef
13.
Zurück zum Zitat Hering K, Bresch A, Lobsien D, Mueller W, Kortmann RD, Seidel C (2016) Primary intradural extramedullary spinal melanoma in the lower thoracic spine. Case Rep Oncol Med 2016:3815280PubMedPubMedCentral Hering K, Bresch A, Lobsien D, Mueller W, Kortmann RD, Seidel C (2016) Primary intradural extramedullary spinal melanoma in the lower thoracic spine. Case Rep Oncol Med 2016:3815280PubMedPubMedCentral
14.
Zurück zum Zitat Hwang JK, Kim KH, Kim JS, Ahn SJ, Kuh SU (2017) Late-developing metastatic malignant melanoma in the thoracic spine originating from choroidal melanoma. Korean J Spine 14:53–56CrossRefPubMedPubMedCentral Hwang JK, Kim KH, Kim JS, Ahn SJ, Kuh SU (2017) Late-developing metastatic malignant melanoma in the thoracic spine originating from choroidal melanoma. Korean J Spine 14:53–56CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Jeong DH, Lee CK, You NK, Kim SH, Cho KH (2013) Primary spinal cord melanoma in thoracic spine with leptomeningeal dissemination and presenting hydrocephalus. Brain Tumor Res Treat 1:116–120CrossRefPubMedPubMedCentral Jeong DH, Lee CK, You NK, Kim SH, Cho KH (2013) Primary spinal cord melanoma in thoracic spine with leptomeningeal dissemination and presenting hydrocephalus. Brain Tumor Res Treat 1:116–120CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Katalinic D, Anic B, Stern-Padovan R et al (2011) Low back pain as the presenting sign in a patient with primary extradural melanoma of the thoracic spine—a metastatic disease 17 years after complete surgical resection. World J Surg Oncol 9:150MCrossRef Katalinic D, Anic B, Stern-Padovan R et al (2011) Low back pain as the presenting sign in a patient with primary extradural melanoma of the thoracic spine—a metastatic disease 17 years after complete surgical resection. World J Surg Oncol 9:150MCrossRef
17.
Zurück zum Zitat Mandaliya H, Singh N, George S, George M (2016) Choroid melanoma metastasis to spine: a rare case report. Case Rep Ophthalmol Med 2016:2732105PubMedPubMedCentral Mandaliya H, Singh N, George S, George M (2016) Choroid melanoma metastasis to spine: a rare case report. Case Rep Ophthalmol Med 2016:2732105PubMedPubMedCentral
18.
Zurück zum Zitat Marx S, Fleck SK, Manwaring J, Vogelgesang S, Langner S, Schroeder HW (2014) Primary leptomeningeal melanoma of the cervical spine mimicking a meningioma—a case report. J Neurol Surg Rep 75:e93–e97CrossRefPubMedPubMedCentral Marx S, Fleck SK, Manwaring J, Vogelgesang S, Langner S, Schroeder HW (2014) Primary leptomeningeal melanoma of the cervical spine mimicking a meningioma—a case report. J Neurol Surg Rep 75:e93–e97CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Shakur SF, Takagi I, Lukas RV, Chmura S, Gajewski TF, Roitberg BZ (2012) Ocular melanoma metastasis to the cervical spine. J Clin Neurosci 19:610–611CrossRefPubMed Shakur SF, Takagi I, Lukas RV, Chmura S, Gajewski TF, Roitberg BZ (2012) Ocular melanoma metastasis to the cervical spine. J Clin Neurosci 19:610–611CrossRefPubMed
20.
Zurück zum Zitat Sun L, Song Y, Gong Q (2013) Easily misdiagnosed delayed metastatic intraspinal extradural melanoma of the lumbar spine: a case report and review of the literature. Oncol Lett 5:1799–1802CrossRefPubMedPubMedCentral Sun L, Song Y, Gong Q (2013) Easily misdiagnosed delayed metastatic intraspinal extradural melanoma of the lumbar spine: a case report and review of the literature. Oncol Lett 5:1799–1802CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Yu J, Zhao DD, Chen S, Zhang JM, Xu J (2012) Primary melanoma of the cervical spine with cerebral metastases: case report and review of the literature. J Int Med Res 40:1207–1215CrossRefPubMed Yu J, Zhao DD, Chen S, Zhang JM, Xu J (2012) Primary melanoma of the cervical spine with cerebral metastases: case report and review of the literature. J Int Med Res 40:1207–1215CrossRefPubMed
23.
Zurück zum Zitat Shankar GM, Choi BD, Grannan BL, Oh K, Shin JH (2017) Effect of immunotherapy status on outcomes in patients with metastatic melanoma to the spine. Spine (Phila Pa 1976) 42:E721–E725CrossRef Shankar GM, Choi BD, Grannan BL, Oh K, Shin JH (2017) Effect of immunotherapy status on outcomes in patients with metastatic melanoma to the spine. Spine (Phila Pa 1976) 42:E721–E725CrossRef
24.
Zurück zum Zitat Coit DG, Thompson JA, Algazi A et al (2016) Melanoma, version 2.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw 14:450–473CrossRef Coit DG, Thompson JA, Algazi A et al (2016) Melanoma, version 2.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw 14:450–473CrossRef
25.
26.
Zurück zum Zitat Tomita K, Kawahara N, Baba H, Tsuchiya H, Nagata S, Toribatake Y (1994) Total en bloc spondylectomy for solitary spinal metastases. Int Orthop 18:291–298CrossRefPubMed Tomita K, Kawahara N, Baba H, Tsuchiya H, Nagata S, Toribatake Y (1994) Total en bloc spondylectomy for solitary spinal metastases. Int Orthop 18:291–298CrossRefPubMed
27.
Zurück zum Zitat Mesfin A, El DMH, Jain A, Hassanzadeh H, Kebaish KM (2015) Total en bloc spondylectomy for primary and metastatic spine tumors. Orthopedics 38:e995–e1000CrossRefPubMed Mesfin A, El DMH, Jain A, Hassanzadeh H, Kebaish KM (2015) Total en bloc spondylectomy for primary and metastatic spine tumors. Orthopedics 38:e995–e1000CrossRefPubMed
28.
Zurück zum Zitat Wu Y, Lin L, Shen Y, Wu H (2018) Comparison between PD-1/PD-L1 inhibitors (nivolumab, pembrolizumab, and atezolizumab) in pre-treated NSCLC patients: evidence from a Bayesian network model. Int J Cancer 143:3038–3040 Wu Y, Lin L, Shen Y, Wu H (2018) Comparison between PD-1/PD-L1 inhibitors (nivolumab, pembrolizumab, and atezolizumab) in pre-treated NSCLC patients: evidence from a Bayesian network model. Int J Cancer 143:3038–3040
Metadaten
Titel
Prognostic factors of patients with spinal malignant melanoma after surgical intervention: a case series of 21 patients and literature review
verfasst von
Zhichao Zhang
Haiyi Gong
Chenglong Zhao
Dongsheng Wang
Ming Qian
Zhipeng Wu
Jianru Xiao
Publikationsdatum
03.01.2019
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 1/2019
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-018-03071-1

Weitere Artikel der Ausgabe 1/2019

Journal of Neuro-Oncology 1/2019 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.